Physician profile
Amar Gulati
NPI 1992200042
$16,675.93
in general payments reported to CMS, 2019-2025
32 companies · $4,866 in 2025
The $4,866 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,577 · 2022: $980 · 2023: $526 · 2024: $3,727 · 2025: $4,866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,835 · Food and Beverage: $2,784 · Consulting Fee: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,834.93 |
| Food and Beverage | $2,784.15 |
| Consulting Fee | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vilex LLC | $3,894.72 | 2025 | Dynex, Fibula Nail |
| Restor3d, INC. | $3,105.56 | 2021 | |
| Stryker Corporation | $2,040.45 | 2021-2025 | Hoffmann, Ortholoc 3di, Prostep Mica |
| Supreme Orthopedic Systems, LLC | $1,623.43 | 2021-2025 | |
| Paragon 28, INC. | $1,191.02 | 2021-2022 | |
| Arthrex, INC. | $1,146.81 | 2024-2025 | |
| Medline Industries LP | $989.73 | 2021 | |
| Abbott Laboratories | $549.41 | 2024-2025 | Diamondback Peripheral |
| Smith+Nephew, INC. | $459.80 | 2021-2025 | Grafix Pl, Smart Tsf, Cadence |
| Musculoskeletal Transplant Foundation INC. | $309.80 | 2022-2023 | |
| Medtronic, INC. | $257.90 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Integra Lifesciences Corporation | $117.23 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Angiodynamics, INC. | $102.51 | 2022 | |
| Globus Medical, INC. | $88.18 | 2022 | |
| Ossio INC | $82.18 | 2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $77.45 | 2023-2024 | Qutenza |
| Boston Scientific Corporation | $76.89 | 2022 | |
| Depuy Synthes Sales INC. | $75.24 | 2023-2025 | Va-Lcp, Na, Dynacord |
| Convatec INC. | $61.06 | 2023-2024 | |
| Organogenesis INC. | $59.25 | 2022-2023 | Puraply |
| Arteriocyte Medical Systems, INC. | $57.41 | 2021 | |
| Paratek Pharmaceuticals, INC. | $57.17 | 2022-2025 | Nuzyra |
| Linvatec Corporation | $42.29 | 2025 | Allograft Tissue, Hercules Syndesmosis Implant System, Colink Afx |
| Progenacare Global, LLC | $31.07 | 2023 | |
| Bioventus LLC | $28.81 | 2021-2022 | |
| Amgen INC. | $28.57 | 2024 | Krystexxa |
| Hartmann USA, INC. | $27.56 | 2022-2025 | Zetuvit Plus 10x10 P10 |
| Solventum Corporation | $24.54 | 2025 | Promogran Prisma, Activ.A.C. |
| Kerecis Limited | $20.76 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.09 | 2024 | Jublia |
| Cashflow Solutions, LLC | $16.98 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Advanced Oxygen Therapy INC. | $14.06 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Gulati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.